Effects of MCU-mediated Ca2+ Homeostasis on Ovarian Cancer Cell SKOV3 Proliferation, Migration and Transformation
Related Experiment Video
Updated: Jul 21, 2026
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Lantao Zhao1, Man Jiang2, Tian Tian3
1Department of Anesthesiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Background:
Atlas human proteomics database showed MCU as highly expressed in various tumor tissues, especially in ovarian cancer. Rare studies on the role of MCU and its regulation in ovarian cancer have been reported.
Objective:
The objective of this study was to determine role of MCU in ovarian cancer cell SKOV3 proliferation, migration, and transformation, and explore the possible mechanism.
Methods:
MCU siRNA on lentiviral particles were stably transfected into SKOV3 cells. CCK-8 assay was performed to analyze cell proliferation. Soft-agar colony formation assay was employed to evaluate tumorigenesis. Western blot and immunohistochemistry analyses were performed to evaluate the expression of MCU, MICU1 and phosphorylate of Akt in the ovarian cancer cell and tissue specimens. Scratch assay was combined with trans-well plates assay to detect the migration ability of cancer cells. The ROS production and Ca2+ expression were also determined.
Results:
MCU expression was significantly higher in ovarian cancer tissues than normal tissues. MCU silencing decreased SKOV3 cell proliferation, migration, and transformation. ROS production was decreased after MCU silencing, depending on disturbed Ca2+ homeostasis. MICU1 expression has been found to be decreased and phosphorylation of Akt increased when MCU was silenced.
Conclusion:
Down-regulation of MCU inhibited SKOV3 cell proliferation, migration, and transformation via disturbing Ca2+ homeostasis and decreasing ROS production. MICU1 and phosphorylation of Akt are associated with MCU-mediated ovarian cancer malignancy.
Insights
Mitochondrial calcium uniporter (MCU) down-regulation inhibits ovarian cancer cell growth and spread. This occurs by disrupting calcium homeostasis and reducing reactive oxygen species (ROS), suggesting MCU as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Mitochondrial calcium uniporter (MCU) is highly expressed in ovarian cancer tissues.
- Limited research exists on MCU's role and regulation in ovarian cancer.
- Understanding MCU's function is crucial for developing targeted ovarian cancer therapies.
Purpose of the Study:
- To investigate the role of MCU in ovarian cancer cell line SKOV3 proliferation, migration, and transformation.
- To elucidate the underlying molecular mechanisms of MCU's involvement in ovarian cancer malignancy.
- To explore potential therapeutic strategies targeting MCU in ovarian cancer.
Main Methods:
- Stable transfection of SKOV3 cells with MCU siRNA using lentiviral particles.
- Cell proliferation assessed by CCK-8 assay; tumorigenesis evaluated by soft-agar assay.
- Migration analyzed using scratch and Transwell assays; ROS and Ca2+ levels determined; Western blot and IHC for protein expression (MCU, MICU1, p-Akt).
Main Results:
- MCU expression is significantly elevated in ovarian cancer tissues compared to normal tissues.
- MCU silencing markedly reduced SKOV3 cell proliferation, migration, and transformation.
- MCU inhibition disturbed Ca2+ homeostasis, decreased ROS production, lowered MICU1 expression, and increased Akt phosphorylation.
Conclusions:
- Down-regulation of MCU inhibits ovarian cancer cell proliferation, migration, and transformation.
- These effects are mediated by disturbed Ca2+ homeostasis and reduced ROS production.
- MICU1 and Akt phosphorylation are implicated in MCU-driven ovarian cancer progression.
